The antifungal treatment market is characterized by dynamic trends reflecting evolving clinical needs, technological capabilities, and healthcare system priorities that collectively shape therapeutic approaches to fungal infections. Increasing recognition of fungal infections as significant causes of morbidity and mortality has elevated their priority within infectious disease...